Orkla India IPO GMP, Price Band, Financials & Allotment Status

Orkla India IPO – An Overview and Company Insight

Orkla India IPO GMP is already attracting attention as the company behind iconic Indian food brands such as MTR and Eastern gears up for its listing. Orkla India Ltd is a multi-category food company offering spices, ready-to-eat meals, breakfast mixes and convenience foods, with a strong presence in both domestic and export markets. The company is backed by Norwegian parent Orkla ASA.

What makes this IPO noteworthy: it is a pure Offer for Sale (OFS)—meaning the company will not receive fresh equity capital; the selling shareholders will. With strong brand recognition, robust distribution infrastructure and exposure to the growth in India’s packaged foods market, the Orkla India IPO is positioned as a marquee offering for retail investors. Having said that, investors should consider that since the company won’t raise fresh funds through this offering, the growth-capital angle is less emphasized and listing‐gain orientation might be stronger.

Orkla India IPO – Grey Market Premium (GMP)

Grey market activity indicates moderate to strong interest. At present, the GMP is around ~ 10-16% above the upper price band, showing that market participants expect listing gains. If this holds, investors could see decent uplift on listing day, though it depends on subscription numbers and market sentiment.

Grey Market Premium – Summary 

Metric	Estimate / Observation
Reported GMP	~ 10-16% above upper price band
Upper Price Band	₹ 730 per share
Implied Listing Price	~ ₹ 800-₹ 820 (approx)
Key Drivers	Strong brand, FMCG tailwinds, export strength
Key Risks	Being an OFS only (no fresh capital), valuation, raw-material pressure

Orkla India IPO GMP

Date	IPO GMP	GMP Trend	Listing Gain
Today	₹105		14.38%
27 Oct	₹160		21.92%
25 Oct	₹145		19.86%
24 Oct	₹115		15.75%

Pricing Details and Lot Size – Orkla India IPO

• Price Band: ₹ 695 to ₹ 730 per share (face value ₹ 1)

• Minimum Lot Size: 20 shares

• Minimum Retail Investment: At upper band 20 × ₹ 730 = ₹ 14,600

• Issue Composition: Entirely an OFS (selling shareholders)

• Allocation Breakdown: Up to ~ 50% to QIBs, at least ~ 15% to NIIs, at least ~ 35% to Retail Investors

Pricing & Lot Size – Summary 

IPO Timelines at a Glance – Orkla India IPO

How To Check the Allotment Status of the Orkla India IPO

Once the allotment is finalised (early November 2025):

• Registrar Website: Visit Kfin Technologies → “IPO Allotment Status” → enter PAN, Application Number or Demat ID → check.

• NSE / BSE Website: Under Corporate Actions → IPO Allotment Status → select Orkla India Ltd. → input PAN / application details.

Make sure you have your PAN/application number/demat ID ready for quick access.

Book-running Lead Managers and Registrar – Orkla India IPO

• Book-running Lead Managers: ICICI Securities Ltd, Citigroup Global Markets India, J.P. Morgan India, Kotak Mahindra Capital Company (among others)

• Registrar: Kfin Technologies Ltd

Offer for Sale and IPO Size Breakdown – Orkla India IPO

• Total Issue Size: ~ ₹ 1,667 crore (approx)

• Fresh Issue: NIL (no new shares issued)

• Offer for Sale (OFS): Entire ~2.28 crore shares sold by selling shareholders (promoter group & other existing shareholders)

Because the company receives no fresh funds, this IPO is essentially an exit route for the promoters and existing shareholders.

Utilisation of Fresh Issuance and Technological Advancements – Orkla India IPO

Since this is purely an OFS, no fresh capital will flow into the company for growth, expansion or debt reduction. All proceeds go to selling shareholders. While this limits the ‘capital infusion’ angle, the company still benefits from listing visibility, enhanced public equity, broader market valuation, and may leverage that to support future strategic growth (e.g., acquisitions, brand building) fiscally from internal resources.

From a technology/infrastructure viewpoint, Orkla India already has strong manufacturing, export and distribution capabilities—investors should watch whether the company uses listing momentum to ramp up innovation, digital supply-chain, exports, or new product lines.

IPO Financial Information

For the year ending March 31, 2025, Orkla India reported revenue of about ₹ 2,394.7 crore and profits (PAT) of ~ ₹ 255.7 crore, showing modest growth in a mature FMCG business. With no fresh capital raising, growth will rely on internal expansion, efficiency gains and leveraging strong brands. Compared with peers in the FMCG/packaged foods space, its valuation may be less aggressive but still deserves scrutiny given competitive pressures and commodity cost inflation.

Financials – Summary 

Conclusion

The Orkla India IPO brings one of India’s respected food brands into the public market. With Orkla India IPO GMP showing a favourable premium and the company’s strong footprints in spices, ready-meals and branded foods, it’s an opportunity worth considering—especially for investors targeting long-term brand-led growth in the FMCG sector. However, being purely an OFS limits fresh capital infusion, so growth expectations must be tempered. Key risks include commodity price volatility, margin pressure, competition and the fact that listing gains may dominate over structural value creation in the short term.

Investing in IPOs Made Simple

Interested in IPOs like Orkla India? You can open a demat account today to apply smoothly when the issue opens. With TradeSmart, you get low brokerage, easy platform access, strong customer support and all you need to participate in IPOs and equity markets with confidence. Click here to open a demat account.

Disclaimer

This article is for informational purposes only and does not constitute investment advice or a recommendation to subscribe to the Orkla India IPO. Investors should read the Red Herring Prospectus (RHP), assess risk factors, compare valuations, and consult a qualified financial advisor before making investment decisions. The Orkla India IPO GMP mentioned is indicative, based on market speculation and may change. TradeSmart and its associates are not liable for any financial loss arising from decisions made based on this content.